Journal Report

Future Oncology

Download PDF
Journal Information
Journal Title
Future Oncology
Publisher
Taylor and Francis Ltd.
ISSN
1479-6694
E-ISSN
1744-8301
Database
SCOPUS
Domain
Health Sciences, Life Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Decitabine and cedazuridine combination therapy in the treatment of acute myeloid leukemia: an evaluation of current evidence
Thura Win Htut, Guillermo Garcia-Manero, Farhad Ravandi
2026-11-14 Pages 1-9
DOI: 10.1080/14796694.2026.2763959
The role of biomarkers in understanding and targeting adaptive resistance in metastatic colorectal cancer
Cody Eslinger, Daniel Ahn, Zhaohui Jin et al.
2026-11-14 Pages 1-12
DOI: 10.1080/14796694.2026.2758043
ASPIRE-GCT: a phase II trial protocol of aspirin thromboprophylaxis during chemotherapy for advanced germ cell tumors
Landon C. Brown, Michael J. McCormack, Antony Ruggeri et al.
2026-11-14 Pages 1-6
DOI: 10.1080/14796694.2026.2759456
Health-related quality of life, symptoms, and burden in metastatic urothelial cancer in Europe: a real-world survey
Mairead Kearney, Mia Unsworth, Cameron Forshaw et al.
2026-11-11 Pages 1-15
DOI: 10.1080/14796694.2026.2756779
Transfusion-related cost and time burden offsets associated with pacritinib versus best available therapy in patients with myelofibrosis: an economic evaluation based on the PERSIST-2 trial
Aaron T. Gerds, Abiola Oladapo, Karisse Roman-Torres et al.
2026-11-11 Pages 1-9
DOI: 10.1080/14796694.2026.2760147
Stereotactic ablative radiotherapy and immunotherapy in metastatic colorectal cancer: overcoming immune resistance through immune priming
Pooya Jalali, Arvin Shahmoradi, Susannah Ellsworth et al.
2026-11-9 Pages 1-15
DOI: 10.1080/14796694.2026.2760682
Diagnostic performance of MRI, endorectal ultrasound, and FAPI PET/MRI for identifying pathological complete response after short-course radiotherapy and chemoimmunotherapy in locally advanced rectal cancer: a retrospective study
Zhihao Hu, Min Chen, Huan Li et al.
2026-11-9 Pages 1-10
DOI: 10.1080/14796694.2026.2760122
Efficacy and safety of Disitamab Vedotin (RC48-ADC) monotherapy versus combination therapy with immune checkpoint inhibitors in solid tumors: a systematic review and meta-analysis
Qing Liangliang, Li Lingyi, Li Xianyong et al.
2026-11-6 Pages 1-12
DOI: 10.1080/14796694.2026.2757484
Treatment outcomes of tucatinib in combination with trastuzumab and pertuzumab as a maintenance therapy for people with HER2+ metastatic breast cancer: a plain language summary of findings from HER2CLIMB-05
Veronique Dieras, Giuseppe Curigliano, Miguel Martin et al.
2026-11-6 Pages 1-10
DOI: 10.1080/14796694.2026.2753928
Zanidatamab in the treatment of esophagogastric adenocarcinoma
Orla M. Fitzpatrick, Geoffrey Y. Ku
2026-11-6 Pages 1-11
DOI: 10.1080/14796694.2026.2760738
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 14, 2026 15:27